The reason I sold out of NVLX is that there is a lot of talk like this but at the end of the day they are still on the starting block. IMHO until the FDA validates that their technology is viable, I will have my doubts that this company will make it. If I am wrong then I would have missed out on a great opportunity. If there is a bump in the road and that is highly very likely, the PPS will be under .10 and I will happily take risk in NVLX at those levels.
News 
Market Data 
Discover 
AI
